Solid Biosciences Inc. — Director's Dealing 2020

Dec 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-12-10

Reporting Person: Shah Rajeev M. (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-10	Common Stock	A	4938282	$3.70	Acquired	8709882	Indirect

Footnotes

F1: The securities reported on this Form 4 exclude 799,564 shares held in an account owned by a separately managed account (the "Account") that were reported on the previous Form 4 filed by Mr. Shah. RA Capital Management, L.P. (the "Adviser") is the investment adviser of the Account. The shares held by the Account have been excluded from the securities reported on this Form 4 pursuant to Rule 16a-1(a)(2)(ii)(C).

F2: The Adviser is the investment manager for the RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The filing of this Form 4 shall not be construed as an admission that Mr. Shah is or was for the purposes of Section 16(a), or otherwise, the beneficial owner of the reported securities, and he disclaims beneficial ownership of the reported securities except to the extent of any pecuniary interest.